Bian Ke - Net Worth and Insider Trading
Bian Ke Net Worth
The estimated net worth of Bian Ke is at least $0 dollars as of 2024-06-21. Bian Ke is the Supervisors of Harbin Pharmaceutical Group Co Ltd and owns about 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) stock worth over $0. Details can be seen in Bian Ke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bian Ke has not made any transactions after 2019-01-11 and currently still holds the listed stock(s).
Transaction Summary of Bian Ke
Bian Ke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bian Ke owns 1 companies in total, including Harbin Pharmaceutical Group Co Ltd (SHSE:600664) .
Click here to see the complete history of Bian Ke’s form 4 insider trades.
Insider Ownership Summary of Bian Ke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600664 | Harbin Pharmaceutical Group Co Ltd | 2019-01-11 | Supervisors |
Bian Ke Latest Holdings Summary
Bian Ke currently owns a total of 1 stock. Bian Ke owns 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) as of January 11, 2019, with a value of $0.
Latest Holdings of Bian Ke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600664 | Harbin Pharmaceutical Group Co Ltd | 2019-01-11 | 0 | 2.73 | 0 |
Holding Weightings of Bian Ke
Bian Ke Form 4 Trading Tracker
According to the SEC Form 4 filings, Bian Ke has made a total of 0 transactions in Harbin Pharmaceutical Group Co Ltd (SHSE:600664) over the past 5 years. The most-recent trade in Harbin Pharmaceutical Group Co Ltd is the sale of 250,000 shares on January 11, 2019, which brought Bian Ke around $747,000.
Insider Trading History of Bian Ke
- 1
Bian Ke Trading Performance
GuruFocus tracks the stock performance after each of Bian Ke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bian Ke is -8.86%. GuruFocus also compares Bian Ke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bian Ke within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bian Ke's insider trading performs compared to the benchmark.
Performance of Bian Ke
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.73 | | | | | |
| Relative Return to S&P 500(%) | -8.01 | | | | | |
Bian Ke Ownership Network
Bian Ke Owned Company Details
What does Harbin Pharmaceutical Group Co Ltd do?
Who are the key executives at Harbin Pharmaceutical Group Co Ltd?
Bian Ke is the Supervisors of Harbin Pharmaceutical Group Co Ltd. Other key executives at Harbin Pharmaceutical Group Co Ltd include senior management Lin Guo Ren , senior management Wang Hai Sheng , and senior management Liu Bo .
Harbin Pharmaceutical Group Co Ltd (SHSE:600664) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Harbin Pharmaceutical Group Co Ltd (SHSE:600664)'s detailed insider trading history can be found in Insider Trading Tracker table.
Harbin Pharmaceutical Group Co Ltd Insider Transactions
Bian Ke Mailing Address
Above is the net worth, insider trading, and ownership report for Bian Ke. Currently GuruFocus does not have mailing address information for Bian Ke.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
